×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Program Committee
-
Daisaku Sato, PhD, MPharm, RPh Director, Compliance & Narcotics Division
Ministry of Health, Labour and Welfare, Japan -
Yasuko Terao, PhD Head, External Scientific Engagement, R&D Japan Region,
Takeda Pharmaceutical Co., Ltd., Japan -
Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan -
Masaki Kasai, PhD Reviewer, Office of Cellular and Tissue-based Products,
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yoshie Tsurumaki Group Manager, Cell & Gene Franchise
Novartis Pharma K.K., Japan -
Kazunobu Oyama, PhD
Daiichi Sankyo Company, Limited, Japan -
Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
Novartis Pharma K.K, Japan -
Masafumi Onodera, MD, PhD Director, Center of Gene Cell Therapy Promotion,
National Center for Child Health and Development, Japan -
Satoru Hayata, MS
Sobi Japan, Japan -
Hiroyuki Suda, MSc VP, Clinical Development Strategy
KORTUC Inc., Japan -
Sumimasa Nagai, MD, PhD Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan -
Yoji Sato, PhD Head, Division of Drugs
National Institute of Health Sciences, Japan -
Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
Janssen Pharmaceutical K.K., Japan
Have an account?